{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:50:50Z","timestamp":1790733050166,"version":"4.1.0"},"reference-count":108,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OTT"],"DOI":"10.2147\/ott.s370874","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T01:55:10Z","timestamp":1682042110000},"page":"283-295","source":"Crossref","is-referenced-by-count":7,"title":["MNK Proteins as Therapeutic Targets in Leukemia"],"prefix":"10.2147","volume":"Volume 16","author":[{"given":"Candice","family":"Mazewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas C","family":"Platanias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1093\/emboj\/16.8.1909","volume":"16","author":"Waskiewicz","year":"1997","journal-title":"EMBO J"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"11134","DOI":"10.1016\/S0021-9258(18)60935-4","volume":"262","author":"Bonneau","year":"1987","journal-title":"J Biol Chem"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"17887","DOI":"10.1074\/jbc.272.28.17887","volume":"272","author":"Morley","year":"1997","journal-title":"J Biol Chem"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"6539","DOI":"10.1128\/MCB.24.15.6539-6549.2004","volume":"24","author":"Ueda","year":"2004","journal-title":"Mol Cell Biol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"13984","DOI":"10.1073\/pnas.1008136107","volume":"107","author":"Ueda","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.cyto.2016.01.024","volume":"89","author":"Kosciuczuk","year":"2017","journal-title":"Cytokine"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"13719","DOI":"10.1021\/acs.jmedchem.1c01084","volume":"64","author":"Han","year":"2021","journal-title":"J Med Chem"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"105675","DOI":"10.1016\/j.bioorg.2022.105675","volume":"121","author":"Yen","year":"2022","journal-title":"Bioorg Chem"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"955","DOI":"10.18632\/oncotarget.27952","volume":"12","author":"Suarez","year":"2021","journal-title":"Oncotarget"},{"key":"ref10","unstructured":"Therapeutics E. A phase 1\u20132 dose-escalation and cohort-expansion study of oral tomivosertib (eFT-508) in subjects with hematological malignancies; 2017. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT02937675. Accessed April 11, 2023."},{"key":"ref11","unstructured":"EDDC ASRE, Inc. CI. Evaluation of ETC-1907206 with dasatinib in advanced haematologic malignancies; 2018. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT03414450. Accessed April 11, 2023."},{"key":"ref12","unstructured":"Jacqueline Garcia M, Lilly E; Company, Institute D-FC. Combination merestinib and LY2874455 for patients with relapsed or refractory acute myeloid leukemia; 2017. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT03125239. Accessed April 11, 2023."},{"key":"ref13","unstructured":"American Cancer Society. Cancer Facts & Figures. American Cancer Society; 2022."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41408-022-00756-9","volume":"12","author":"Hampel","year":"2022","journal-title":"Blood Cancer J"},{"key":"ref17","first-page":"92","volume":"19","author":"Kay","year":"2021","journal-title":"Clin Adv Hematol Oncol"},{"key":"ref18","unstructured":"American Cancer Society. Treating Acute Lymphocytic Leukemia (ALL). American Cancer Society; 2021."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.6004\/jnccn.2020.0047","volume":"18","author":"Deininger","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"721","DOI":"10.6004\/jnccn.2019.0028","volume":"17","author":"Tallman","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1016\/S2352-3026(22)00292-7","volume":"10","author":"Watts","year":"2022","journal-title":"Lancet Haematol"},{"key":"ref22","unstructured":"Administration FaD. FDA Approves Olutasidenib for Relapsed or Refractory Acute Myeloid Leukemia with a Susceptible IDH1 Mutation. Administration FaD; 2023:ed2022."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1182\/blood-2017-05-782292","volume":"129","author":"Levis","year":"2017","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41375-019-0704-5","volume":"34","author":"Estey","year":"2020","journal-title":"Leukemia"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1093\/emboj\/16.8.1921","volume":"16","author":"Fukunaga","year":"1997","journal-title":"EMBO J"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"5359","DOI":"10.2741\/3086","volume":"13","author":"Buxade","year":"2008","journal-title":"Front Biosci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1128\/MCB.21.3.743-754.2001","volume":"21","author":"Scheper","year":"2001","journal-title":"Mol Cell Biol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1593\/neo.10704","volume":"12","author":"Li","year":"2010","journal-title":"Neoplasia"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"38649","DOI":"10.1074\/jbc.M407337200","volume":"279","author":"Orton","year":"2004","journal-title":"J Biol Chem"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.celrep.2017.01.023","volume":"18","author":"Brown","year":"2017","journal-title":"Cell Rep"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00018-020-03491-1","volume":"78","author":"Xie","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"109689","DOI":"10.1016\/j.cellsig.2020.109689","volume":"73","author":"Yang","year":"2020","journal-title":"Cell Signal"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"711","DOI":"10.32604\/biocell.2021.014193","volume":"45","author":"Zhou","year":"2021","journal-title":"Biocell"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4331\/wjbc.v5.i3.321","volume":"5","author":"Joshi","year":"2014","journal-title":"World J Biol Chem"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1128\/MCB.26.5.1898-1907.2006","volume":"26","author":"DaSilva","year":"2006","journal-title":"Mol Cell Biol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1074\/jbc.M109.030882","volume":"285","author":"Edwin","year":"2010","journal-title":"J Biol Chem"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1074\/jbc.M705286200","volume":"283","author":"Buxade","year":"2008","journal-title":"J Biol Chem"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.immuni.2005.06.009","volume":"23","author":"Buxade","year":"2005","journal-title":"Immunity"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"37542","DOI":"10.1074\/jbc.M003395200","volume":"275","author":"Hefner","year":"2000","journal-title":"J Biol Chem"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1242\/jcs.127779","volume":"126","author":"Bouameur","year":"2013","journal-title":"J Cell Sci"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1182\/blood.2022015568","volume":"140","author":"Manne","year":"2022","journal-title":"Blood"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1111\/cbdd.13585","volume":"94","author":"Mishra","year":"2019","journal-title":"Chem Biol Drug Des"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.str.2005.07.013","volume":"13","author":"Jauch","year":"2005","journal-title":"Structure"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1128\/MMBR.00031-10","volume":"75","author":"Cargnello","year":"2011","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1021\/acs.jmedchem.7b01795","volume":"61","author":"Reich","year":"2018","journal-title":"J Med Chem"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1021\/acs.jmedchem.7b01714","volume":"61","author":"Yang","year":"2018","journal-title":"J Med Chem"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1172\/JCI91258","volume":"127","author":"Zhan","year":"2017","journal-title":"J Clin Invest"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.canlet.2016.12.029","volume":"390","author":"Santag","year":"2017","journal-title":"Cancer Lett"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1128\/MCB.21.16.5500-5511.2001","volume":"21","author":"Knauf","year":"2001","journal-title":"Mol Cell Biol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s10637-012-9912-9","volume":"31","author":"Yan","year":"2013","journal-title":"Invest New Drugs"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1021\/acs.jmedchem.9b01582","volume":"63","author":"Kwiatkowski","year":"2020","journal-title":"J Med Chem"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.1016\/j.bmc.2018.05.004","volume":"26","author":"Wang","year":"2018","journal-title":"Bioorg Med Chem"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/cmdc.201300552","volume":"9","author":"Diab","year":"2014","journal-title":"ChemMedChem"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ejmech.2018.10.070","volume":"162","author":"Jin","year":"2019","journal-title":"Eur J Med Chem"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1021\/bi501261j","volume":"54","author":"Kannan","year":"2015","journal-title":"Biochemistry"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"7881","DOI":"10.1021\/acsomega.7b01403","volume":"2","author":"Kannan","year":"2017","journal-title":"ACS Omega"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1021\/acs.jmedchem.1c00368","volume":"65","author":"Xu","year":"2022","journal-title":"J Med Chem"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"6070","DOI":"10.1021\/acs.jmedchem.1c01941","volume":"65","author":"Bou-Petit","year":"2022","journal-title":"J Med Chem"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1021\/cb500886n","volume":"10","author":"Hantschel","year":"2015","journal-title":"ACS Chem Biol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1016\/j.bmcl.2019.07.043","volume":"29","author":"Abdelaziz","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"602","DOI":"10.2174\/1573406415666181219111511","volume":"15","author":"Abdelaziz","year":"2019","journal-title":"Med Chem"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1107\/S2053230X18002108","volume":"74","author":"Matsui","year":"2018","journal-title":"Acta Crystallogr Struct Biol Commun"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.3390\/molecules23092126","volume":"23","author":"Sansook","year":"2018","journal-title":"Molecules"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.3390\/biom11111670","volume":"11","author":"Halder","year":"2021","journal-title":"Biomolecules"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1021\/np030096l","volume":"66","author":"Newman","year":"2003","journal-title":"J Nat Prod"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.3390\/molecules26092709","volume":"26","author":"Cotoraci","year":"2021","journal-title":"Molecules"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"168","DOI":"10.2188\/jea.8.168","volume":"8","author":"Kimira","year":"1998","journal-title":"J Epidemiol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"6147","DOI":"10.1021\/jf500639f","volume":"62","author":"Bower","year":"2014","journal-title":"J Agric Food Chem"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s40495-017-0113-2","volume":"3","author":"Shankar","year":"2017","journal-title":"Curr Pharmacol Rep"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"154061","DOI":"10.1016\/j.phymed.2022.154061","volume":"100","author":"Yen","year":"2022","journal-title":"Phytomedicine"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.bbrc.2016.06.158","volume":"477","author":"Pan","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/CAD.0000000000001421","volume":"34","author":"Cai","year":"2022","journal-title":"Anticancer Drugs"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1021\/acs.jnatprod.0c00516","volume":"83","author":"Chen","year":"2020","journal-title":"J Nat Prod"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1021\/jo00003a002","volume":"56","author":"Sugawara","year":"1991","journal-title":"J Org Chem"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1158\/0008-5472.CAN-10-3298","volume":"71","author":"Konicek","year":"2011","journal-title":"Cancer Res"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"102971","DOI":"10.1016\/j.bioorg.2019.102971","volume":"89","author":"Wang","year":"2019","journal-title":"Bioorg Chem"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1182\/blood-2013-01-477216","volume":"121","author":"Altman","year":"2013","journal-title":"Blood"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1182\/blood-2016-02-698704","volume":"128","author":"Kosciuczuk","year":"2016","journal-title":"Blood"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"7112","DOI":"10.18632\/oncotarget.27388","volume":"10","author":"Kosciuczuk","year":"2019","journal-title":"Oncotarget"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"E2298","DOI":"10.1073\/pnas.1301838110","volume":"110","author":"Lim","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref81","volume-title":"Fundamental and Clinical Pharmacology","year":"2022"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.cellsig.2016.06.005","volume":"28","author":"Grzmil","year":"2016","journal-title":"Cell Signal"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/fcp.12759","volume":"36","author":"Yang","year":"2022","journal-title":"Fundam Clin Pharmacol"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1093\/jpp\/rgab094","volume":"73","author":"Zhu","year":"2021","journal-title":"J Pharm Pharmacol"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1124\/mol.110.064642","volume":"78","author":"Altman","year":"2010","journal-title":"Mol Pharmacol"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"56811","DOI":"10.18632\/oncotarget.10796","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.2147\/OTT.S143465","volume":"11","author":"Chen","year":"2018","journal-title":"Onco Targets Ther"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"6496","DOI":"10.1128\/MCB.00477-08","volume":"28","author":"Zhang","year":"2008","journal-title":"Mol Cell Biol"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.bbrc.2016.08.047","volume":"478","author":"Liu","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1158\/2159-8290.CD-20-0652","volume":"11","author":"Knight","year":"2021","journal-title":"Cancer Discov"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2020102118","volume":"118","author":"Fan","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1038\/s41401-018-0161-0","volume":"39","author":"Huang","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.canlet.2014.12.029","volume":"357","author":"Teo","year":"2015","journal-title":"Cancer Lett"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1084\/jem.20110846","volume":"208","author":"Schatz","year":"2011","journal-title":"J Exp Med"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"975191","DOI":"10.3389\/fchem.2022.975191","volume":"10","author":"Mohamed","year":"2022","journal-title":"Front Chem"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/leu.2015.180","volume":"30","author":"Wu","year":"2016","journal-title":"Leukemia"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1021\/acs.jmedchem.5b01712","volume":"59","author":"Cherian","year":"2016","journal-title":"J Med Chem"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.3390\/molecules25184318","volume":"25","author":"Xing","year":"2020","journal-title":"Molecules"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.3390\/cancers11111794","volume":"11","author":"San Jose-Eneriz","year":"2019","journal-title":"Cancers"},{"key":"ref100","unstructured":"Oncology TRi, Therapeutics E, Cancer SUT. Safety, pharmacodynamics, pharmacokinetics, and efficacy of tomivosertib combined with paclitaxel in advanced breast cancer; 2020. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT04261218. Accessed April 11, 2023."},{"key":"ref101","unstructured":"Therapeutics E. An open-label study examining the effect of tomivosertib (eFT508) in patients with advanced castrate-resistant prostate cancer (CRPC); 2018. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT03690141. Accessed April 11, 2023."},{"key":"ref102","unstructured":"Therapeutics E. Tomivosertib (eFT-508) in combination with PD-1\/PD-L1 inhibitor therapy; 2018. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT03616834. Accessed April 11, 2023."},{"key":"ref103","unstructured":"Therapeutics E, Medpace I. Tomivosertib combined with pembrolizumab in subjects with PD-L1 positive NSCLC (KICKSTART). Available from: https:\/\/ClinicalTrials.gov\/show\/NCT04622007;. Accessed April 11, 2023.2021."},{"key":"ref104","unstructured":"Therapeutics E, Merck KGaA D, Germany, Pfizer. A study to evaluate eFT508 alone and in combination with avelumab in subjects with MSS colorectal cancer; 2017. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT03258398. Accessed April 11, 2023."},{"key":"ref105","unstructured":"Therapeutics E. A PD study of oral eFT508 in subjects with advanced TNBC and HCC; 2017. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT03318562. Accessed April 11, 2023."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1158\/1078-0432.CCR-22-2540","volume":"29","author":"Chen","year":"2023","journal-title":"Clin Cancer Res"},{"key":"ref107","unstructured":"eFFECTOR therapeutics\u2019 lead product candidate, eFT508, receives orphan designation from FDA for treatment of diffuse large B-cell lymphoma [press release] eFFECTOR Therapeutics; 2017. Available from: https:\/\/www.prnewswire.com\/news-releases\/effector-therapeutics-lead-product-candidate-eft508-receives-orphan-designation-from-fda-for-treatment-of-diffuse-large-b-cell-lymphoma-300420884.html. Accessed January 4, 2023."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","volume":"49","author":"Kim","year":"2019","journal-title":"Nucleic Acids Res"}],"container-title":["OncoTargets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=89156","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=89156","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T01:55:37Z","timestamp":1682042137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/mnk-proteins-as-therapeutic-targets-in-leukemia-peer-reviewed-fulltext-article-OTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":108,"URL":"https:\/\/doi.org\/10.2147\/ott.s370874","relation":{},"ISSN":["1178-6930"],"issn-type":[{"value":"1178-6930","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]}}}